Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-070869
Filing Date
2023-06-13
Accepted
2023-06-13 17:06:17
Documents
6
Effectiveness Date
2023-06-13

Document Format Files

Seq Description Document Type Size
1 S-8 tm2318498d1_s8.htm S-8 73342
2 EXHIBIT 5.1 tm2318498d1_ex5-1.htm EX-5.1 11193
3 EXHIBIT 23.1 tm2318498d1_ex23-1.htm EX-23.1 2413
4 EX-FILING FEES tm2318498d1_ex-filingfees.htm EX-FILING FEES 18479
5 GRAPHIC tm2318498d1_ex5-1img001.jpg GRAPHIC 3865
6 GRAPHIC tm2318498d1_ex5-1img002.jpg GRAPHIC 2711
  Complete submission text file 0001104659-23-070869.txt   115897
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272621 | Film No.: 231012063
SIC: 2834 Pharmaceutical Preparations